An unrelated donor (UD) search was submitted to the Italian Bone Marrow Donor Registry between February 2002 and December 2004, for 326 consecutive patients with hematological malignancies, eligible for a reduced intensity conditioning (RIC) UD transplant. Only two regimens were allowed: melphalan, alemtuzumab, fludarabine and total body irradiation of 200 cGy (regimen A) and thiotepa, cyclophosphamide, anti-thymocyte globulin (regimen B). The outcome of patients receiving an UD transplant (n=121) was compared with patients who did not find a donor (n=205), in a time dependent analysis, correcting for time to transplant. The median follow up from activation of donor search was 6.1 years. UD transplant was associated with a significantly better survival in patients with acute leukemia and non-Hodgkin's lymphoma (NHL) whereas only a favorable trend was documented for Hodgkin's disease. No survival benefit was registered for chronic leukemias. The outcome of the two different conditioning regimens was comparable, in terms of survival, transplant-related mortality and graft versus host disease. In conclusion, finding an UD and undergoing a RIC transplant significantly improves survival of patients with acute leukemia and NHL. The advantage is less clear for HD and chronic leukemias. The role of different conditioning regimens remains to be elucidated by prospective clinical trials.

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients / Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A. - In: LEUKEMIA. - ISSN 1476-5551. - 26:3(2012), pp. 1779-1785. [10.1038/leu.2012.55]

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

Carobbio A;
2012

Abstract

An unrelated donor (UD) search was submitted to the Italian Bone Marrow Donor Registry between February 2002 and December 2004, for 326 consecutive patients with hematological malignancies, eligible for a reduced intensity conditioning (RIC) UD transplant. Only two regimens were allowed: melphalan, alemtuzumab, fludarabine and total body irradiation of 200 cGy (regimen A) and thiotepa, cyclophosphamide, anti-thymocyte globulin (regimen B). The outcome of patients receiving an UD transplant (n=121) was compared with patients who did not find a donor (n=205), in a time dependent analysis, correcting for time to transplant. The median follow up from activation of donor search was 6.1 years. UD transplant was associated with a significantly better survival in patients with acute leukemia and non-Hodgkin's lymphoma (NHL) whereas only a favorable trend was documented for Hodgkin's disease. No survival benefit was registered for chronic leukemias. The outcome of the two different conditioning regimens was comparable, in terms of survival, transplant-related mortality and graft versus host disease. In conclusion, finding an UD and undergoing a RIC transplant significantly improves survival of patients with acute leukemia and NHL. The advantage is less clear for HD and chronic leukemias. The role of different conditioning regimens remains to be elucidated by prospective clinical trials.
2012
26
3
1779
1785
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients / Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A. - In: LEUKEMIA. - ISSN 1476-5551. - 26:3(2012), pp. 1779-1785. [10.1038/leu.2012.55]
Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1331610
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 12
social impact